Announcement on the Cancellation of Repurchased H Shares
Filed with SSE · · 2 pages · Chinese
Summary by 6ix AI
Shanghai Haohai Biological Technology Co., Ltd. announced the cancellation of repurchased H shares. The cancellation was completed on a specific date, and the company will update its articles of association accordingly. The filing confirms the new share structure following the cancellation of the H shares.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shanghai Haohai Biological Technology Co., Ltd. on 6ix
Earlier from Shanghai Haohai Biological Technology
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Voluntary Disclosure of the Holding Subsidiary’s Trifocal Intraocular Lens Product Obtaining the Medical Device Registration Certificate
- Announcement on Adjusting the Total Cash Dividends for the 2025 Annual Profit Distribution
- Announcement on Notifying Creditors in Connection with the Repurchase of H-share Stocks
- Announcement on Result of Shareholding Reduction by Shareholder
Later from Shanghai Haohai Biological Technology
- Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate for Trifocal Toric Intraocular Lens Product of the Controlled Subsidiary
- Announcement on the Profit Distribution Plan for the First Half of 2026
- Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Biological Products and CXO Industry
- Announcement on Adjustment of the Total Cash Dividend Amount for the 2026 Semi-annual Profit Distribution
- (688366)"Shanghai Haohai Biological Technology Co., Ltd."Report for Q3 2026
Follow Shanghai Haohai Biological Technology into a list and get an email when it puts out news.
Follow Shanghai Haohai Biological Technology